Selected Publications

Academic Article

Year Title Altmetric
2018 Use of Medicare Claims Data for the Identification of Myocardial Infarction: The Reasons for Geographic And Racial Differences in Stroke Study.Medical Care.  56:1051-1059. 2018
2018 Is Rheumatoid Arthritis a Cardiovascular Risk-Equivalent to Diabetes Mellitus?Arthritis Care and Research.  70:1694-1699. 2018
2018 An Observational Study of Cardiovascular Risks Associated with Rheumatoid Arthritis Therapies: A Comparison of Two Analytical Approaches.The Permanente Journal.  22. 2018
2018 Gastrointestinal Perforations with Biologics in Patients with Rheumatoid Arthritis: Implications for Clinicians.Drug Safety.  41:545-553. 2018
2018 Reply.Arthritis and Rheumatology.  70:795-796. 2018
2018 Socioeconomic Status and Race are both Independently associated with Increased Hospitalization Rate among Crohn's Disease Patients.Scientific Reports.  8:4028. 2018
2018 Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease.American Journal of Gastroenterology.  113:405-417. 2018
2018 Satisfaction with Subcutaneous Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients with Inadequate Response to Adalimumab or Etanercept.Patient.  11:361-369. 2018
2017 Biomarker-related risk for myocardial infarction and serious infections in patients with rheumatoid arthritis: a population-based study.Annals of the Rheumatic Diseases.  77:386-392. 2017
2017 Accuracy of Medicare Claim-based Algorithm to Detect Breast, Prostate, or Lung Cancer Bone Metastases.Medical Care.  55:e144-e149. 2017
2017 Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study.Arthritis Research.  19:228. 2017
2017 Availability of healthcare resources and epithelial ovarian cancer stage of diagnosis and mortality among Blacks and Whites.Journal of Ovarian Research.  10:57. 2017
2017 Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United States.Arthritis and Rheumatology.  69:1733-1740. 2017
2017 Longterm Effectiveness of Herpes Zoster Vaccine among Patients with Autoimmune and Inflammatory Diseases.Journal of Rheumatology.  44:1083-1087. 2017
2017 The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights.Pharmacoepidemiology and Drug Safety.  26:310-319. 2017
2017 Herpes Zoster and the Risk of Stroke in Patients With Autoimmune Diseases.Arthritis and Rheumatology.  69:439-446. 2017
2017 Perioperative Timing of Infliximab and the Risk of Serious Infection After Elective Hip and Knee Arthroplasty.Arthritis Care and Research.  69:1845-1854. 2017
2016 Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis.Arthritis Care and Research.  69:1526-1534. 2016
2016 Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis.Annals of the Rheumatic Diseases.  75:1813-1818. 2016
2016 Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis.Annals of the Rheumatic Diseases.  75:1843-1847. 2016
2016 Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments.Arthritis and Rheumatology.  68:2612-2617. 2016
2016 Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.Arthritis and Rheumatology.  68:2403-2411. 2016
2016 Accuracy of Medicare Claim-based Algorithm to Detect Breast, Prostate, or Lung Cancer Bone Metastases.Medical Care2016
2016 Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination.Arthritis and Rheumatology.  68:2328-2337. 2016
2016 LDL cholesterol response and statin adherence among high-risk patients initiating treatment.American Journal of Managed Care.  22:e106-e115. 2016
2016 Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer.JAMA Dermatology.  152:164-172. 2016
2016 Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare.Arthritis and Rheumatology.  68:56-66. 2016
2016 LDL cholesterol response and statin adherence among high-risk patients initiating treatmentJournal of Managed Care && Speciality Pharmacy.  22:e106-e115. 2016
2015 The comparative effectiveness of biologics among older adults and disabled rheumatoid arthritis patients in the Medicare population.British Journal of Clinical Pharmacology.  80:1447-1457. 2015
2015 Reply: To PMID 25201241.Arthritis Care and Research.  67:1041-1042. 2015
2015 Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy.Annals of the Rheumatic Diseases.  74:1065-1071. 2015
2015 Risk of hospitalized infection among rheumatoid arthritis patients concurrently treated with a biologic agent and denosumab.Arthritis and Rheumatology.  67:1456-1464. 2015
2015 Fractures and mortality in relation to different osteoporosis treatments.Clinical and Experimental Rheumatology.  33:302-309. 2015
2015 Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients.Arthritis Care and Research.  67:624-632. 2015
2015 Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy.Arthritis Care and Research.  67:731-736. 2015
2015 Cost and effectiveness of biologics for rheumatoid arthritis in a commercially insured population.Journal of Managed Care && Speciality Pharmacy.  21:318-329. 2015
2015 Statin use following hospitalization among Medicare beneficiaries with a secondary discharge diagnosis of acute myocardial infarction.Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.  4. 2015
2015 Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease.Journal of the American College of Cardiology.  65:270-277. 2015
2015 Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary eventAmerican Journal of Cardiology.  114:826-831. 2015
2014 Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research.Arthritis Care and Research.  66:1790-1798. 2014
2014 Use of oral and subcutaneous methotrexate in rheumatoid arthritis patients in the United States.Arthritis Care and Research.  66:1604-1611. 2014
2014 Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event.American Journal of Cardiology.  114:826-831. 2014
2014 Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetes.Annals of Epidemiology.  24:581-587. 2014
2014 Statin underuse and low prevalence of LDL-C control among U.S. adults at high risk of coronary heart disease.American Journal of the Medical Sciences.  348:108-114. 2014
2014 Use of a validated algorithm to estimate the annual cost of effective biologic treatment for rheumatoid arthritis.Journal of Medical Economics (JME).  17:555-566. 2014
2014 Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claims.Clinical Therapeutics.  36:996-1004. 2014
2014 Patterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiaries.BMC Musculoskeletal Disorders.  15:112. 2014
2014 Trends in the utilization and outcomes of Medicare patients hospitalized for hip fracture, 2000-2008.Journal of Aging and Health.  26:360-379. 2014
2014 Death, debility, and destitution following hip fracture.Journals of Gerontology, Series A.  69:346-353. 2014
2013 Identifying newly approved medications in Medicare claims data: a case study using tocilizumab.Pharmacoepidemiology and Drug Safety.  22:1214-1221. 2013
2013 Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US medicare program.Arthritis Care and Research.  65:1743-1751. 2013
2013 Awareness, treatment, and control of LDL cholesterol are lower among U.S. adults with undiagnosed diabetes versus diagnosed diabetes.Diabetes Care.  36:2734-2740. 2013
2013 Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 through 2009-2010.American Journal of Cardiology.  112:664-670. 2013
2013 New methods for determining comparative effectiveness in rheumatoid arthritis.Current Opinion in Rheumatology.  25:325-333. 2013
2013 Further evaluation of a claims-based algorithm to determine the effectiveness of biologics for rheumatoid arthritis using commercial claims data.Arthritis Research.  15:404. 2013
2013 Physicians' explanations for apparent gaps in the quality of rheumatology care: results from the US Medicare Physician Quality Reporting System.Arthritis Care and Research.  65:235-243. 2013
2013 Generic alendronate use among Medicare beneficiaries: are Part D data complete?Pharmacoepidemiology and Drug Safety.  22:55-63. 2013
2012 Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data.Arthritis Care and Research.  64:1855-1863. 2012
2012 Recent trends in hip fracture rates by race/ethnicity among older US adults.Journal of Bone and Mineral Research.  27:2325-2332. 2012
2012 Adherence with intravenous zoledronate and intravenous ibandronate in the United States Medicare population.Arthritis Care and Research.  64:1054-1060. 2012
2012 Central DXA utilization shifts from office-based to hospital-based settings among medicare beneficiaries in the wake of reimbursement changes.Journal of Bone and Mineral Research.  27:858-864. 2012
2011 Minor, major, low-trauma, and high-trauma fractures: what are the subsequent fracture risks and how do they vary?Current Osteoporosis Reports.  9:122-128. 2011
2011 Clinical and demographic factors associated with fractures among older Americans.Osteoporosis International.  22:1263-1274. 2011
2011 Erratum: Clinical and demographic factors associated with fractures among older Americans (Osteoporosis International DOI: 10.1007/s00198-010-1300-8)Osteoporosis International.  22:1275-1276. 2011
2010 Predicting hip and major osteoporotic fractures using administrative data.Archives of Internal Medicine -New Series-.  170:1940-1942. 2010
2010 Health services utilization after fractures: evidence from Medicare.Journals of Gerontology, Series A.  65:1012-1020. 2010
2010 Identifying types of nursing facility stays using medicare claims data: An algorithm and validationHealth Services and Outcomes Research Methodology.  10:100-110. 2010
2009 Health care expenditures associated with skeletal fractures among Medicare beneficiaries, 1999-2005.Journal of Bone and Mineral Research.  24:2050-2055. 2009
2009 Estimated prevalence and patterns of presumed osteoporosis among older Americans based on Medicare data.Osteoporosis International.  20:1507-1515. 2009
2009 The effects of the Balanced Budget Act of 1997 on home health and hospice in older adult cancer patients.Medical Care.  47:279-285. 2009
2008 Adaptation of Bayesian data mining algorithms to longitudinal claims data: coxib safety as an example.Medical Care.  46:969-975. 2008
2008 Does cholecystectomy prior to the diagnosis of pancreatic cancer affect outcome?American Surgeon.  74:602-605. 2008
2008 Secondary analysis of merged American Hospital Association data and U.S. Census data: beginning to understand the supply-demand chain in pediatric inpatient care.Journal of Pediatric Nursing.  23:161-168. 2008
2006 Trends in hospital and surgeon volume and operative mortality for cancer surgery.Annals of Surgical Oncology.  13:851-858. 2006
2005 Physician supply, treatment, and amputation rates for peripheral arterial disease.Journal of Vascular Surgery.  42:81-87. 2005

Education And Training

  • Doctor of Medicine, Foreign University
  • Doctor of Philosophy in Epidemiology, University of Alabama at Birmingham
  • Master of Health Related in Health and Medical Biostatistics, Foreign University
  • Master of Sciences or Mathematics in Biostatistics, University of Alabama at Birmingham
  • Full Name

  • Huifeng Yun
  • Blazerid

  • yunn